跳至主要内容
临床试验/NL-OMON20928
NL-OMON20928招募中不适用

Algorithm to control Postprandial, Post exercise and night glucose Excursions in a portable Closed Loop format in patients after Total Pancreatectomy

Amsterdam UMC (Academic Medical Center)0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who underwent total pancreatectomy;
  • Diabetes treatment with continuous subcutaneous insulin infusion, sensor augmented pump therapy or subcutaneous insulin injections;
  • Age =18 years.

排除标准

  • Total pancreatectomy was performed within less than 3 months before start of the trial;
  • Impaired awareness of hypoglycemia (score = 4) according to Gold and/or Clarke questionnaire;11,12
  • BMI > 35 kg/m2;
  • HbA1c > 90 mmol/mol;
  • Use of oral corticosteroids;
  • Use of acetaminophen during the open loop or closed loop period, as this may influence the sensor glucose measurements;
  • Limited ability to see, and to hear or feel alarm signals of the closed loop system;
  • Refusal of disconnecting own glucose sensors during the closed loop system study period;
  • Pregnancy and/or breastfeeding;
  • Living alone during the night during the closed loop period (the patient may ask someone to stay over temporarily);
  • Any condition that the local investigator feels would interfere with study participation or the evaluation of the results.
  • Patients who are not motivated or not willing to comply with the artificial pancreas therapy;
  • Patients undergoing treatment with Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, X-ray or high frequency electrical heat (diathermy) treatment while wearing the AP system (must be removed);
  • Patients using the artificial pancreas system during sauna or swimming;
  • Known or suspected allergies or problems related to subcutaneous administration of insulin or glucagon;
  • Artificial pancreas therapy is not recommended for people who are unwilling or unable to maintain contact with their medical professional;
  • Alcohol and drug abusing patients;
  • Patients with insufficient general mental and physical abilities;
  • Known or suspected problems related to enzyme based glucose sensor usage;
  • Patients receiving dialysis.

研究者

发起方
Amsterdam UMC (Academic Medical Center)

相似试验